Beacon Pharmaceuticals PLC
113.50
BDT
+1.50
+1.34%
Last updated on 26 May, 10:04
Today
1.34%
1 Week
15.82%
1 Month
-1.99%
6 Month
-7.20%
1 Year
-25.08%
5 Year
86.99%
Matket Today
Open
113.5
BDT
Low
113.5
BDT
High
113.5
BDT
Volume
1
Value
0.00
Crore
Trade
1
YCP
112
BDT
52W Low
87.4
BDT
52W High
169
BDT
Circuit Low
100.8
BDT
Circuit Up
123.2
BDT
Beta (1 Year)
1.57
Financial Indicators
P/E ratio
22.70
EPS (TTM)
5.00
NAV (Q3 2025)
27.80
Total Shares
23.10
Crore
Shot-term loan
759.03
Crore
Long-term loan
272.89
Crore
Market Capital
2573.34
Crore
Paid-up Capital
231.00
Crore
Authorized Capital
300
Crore
Last AGM Date
23 Dec 2024
Last Record Date
27 Oct 2024
Year End
30-Jun
About Beacon Pharmaceuticals PLC
Sector
Pharmaceuticals & Chemicals
Listing Year
2010
beacon@beaconpharma.com.bd
Established in 2006, Beacon Pharmaceuticals PLC has rapidly grown to become the leading oncology company and one of the fastest-growing pharmaceutical companies in Bangladesh. The company boasts state-of-the-art manufacturing facilities adhering to global standards like US FDA, UK MHRA, TGA Australia, and WHO GMP. Specializing in oncology, biotech, hi-tech, and general pharmaceuticals, Beacon manufactures over 200 world-class generic drugs and has introduced several global first generic drugs. Beyond catering to local demand, Beacon exports its medicines to various countries in Asia, Africa, Europe, and Latin America. The company's focus on oncology, commitment to innovation, and adherence to international quality standards have positioned it as a prominent player in the global pharmaceutical landscape.